AdAlta has had an exciting start to 2019 and we are pleased to share with you its first Shareholder Update for 2019. The update, which can be viewed below and downloaded here, includes an update on the progress of AD-214 to the clinic, further details on the collaboration with Excellerate Bioscience and links to all AdAlta mentions in the media as well as upcoming investor events.
Adalta Corporate Newsletter June 2019 4pp FINAL
